163 results
Page 5 of 9
8-K
EX-99.1
xpiqwdihmefo qybyvwj
2 Dec 19
FibroGen Announces Roxadustat Inclusion in China’s National Reimbursement Drug List
7:10am
8-K
exz wuv5lqh
2 Dec 19
FibroGen Announces Roxadustat Inclusion in China’s National Reimbursement Drug List
7:10am
8-K
EX-99.2
ak090sbm
12 Nov 19
FibroGen Reports Third Quarter 2019 Financial Results
8:16am
8-K
EX-99.1
h59ueumz
12 Nov 19
FibroGen Reports Third Quarter 2019 Financial Results
8:16am
8-K
EX-99.1
yjvm83tywydrxjtze
8 Nov 19
Regulation FD Disclosure
2:05pm
8-K
m1lqgbrlpyowx
8 Nov 19
Regulation FD Disclosure
2:05pm
8-K
jx3o4ezmv
8 Nov 19
FibroGen Announces Positive Phase 3 Pooled Roxadustat Safety and Efficacy Results for Treatment of Anemia in Chronic Kidney Disease
2:00pm
8-K
EX-99.1
duyerr 5h
8 Nov 19
FibroGen Announces Positive Phase 3 Pooled Roxadustat Safety and Efficacy Results for Treatment of Anemia in Chronic Kidney Disease
2:00pm
8-K
jfxb tpf6m
11 Oct 19
Regulation FD Disclosure
11:49am
8-K
EX-99.1
1i5jvo skbg
11 Oct 19
Regulation FD Disclosure
11:49am
8-K
EX-99.1
iplae5u7hbb54 xl2
26 Sep 19
FibroGen Announces Initiation of Phase 2 Clinical Trial of Roxadustat for the Treatment
9:01am
8-K
klqdy6nhni06lvur 2dd
20 Sep 19
Roxadustat Approved in Japan for the Treatment of Anemia Associated with Chronic Kidney Disease in Dialysis Patients
9:00am
8-K
EX-99.1
x70di5zu879s1bcpz
20 Sep 19
Roxadustat Approved in Japan for the Treatment of Anemia Associated with Chronic Kidney Disease in Dialysis Patients
9:00am
8-K
EX-99.1
9n4rgflz6yji6vj6
26 Aug 19
Departure of Directors or Certain Officers
9:04am
8-K
qhbmooe
21 Aug 19
Roxadustat Approved In China for Treatment of Anemia In Chronic Kidney Disease Patients Not Receiving Dialysis
4:39pm
8-K
EX-99.1
w5c9xfvjgv 4c
21 Aug 19
Roxadustat Approved In China for Treatment of Anemia In Chronic Kidney Disease Patients Not Receiving Dialysis
4:39pm
8-K
EX-99.1
7tfemf8 2gwm2wpamm6
8 Aug 19
Fibrogen Reports Second Quarter 2019 Financial Results
4:15pm
8-K
vrydc 8qk
24 Jul 19
Other Events
9:46pm